Clinical Trial Update: Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether adding L-carnitine to methylphenidate improves ADHD symptoms; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• L-carnitine (L-carnitine)
• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: UNKNOWN